What is Regenxbio's total liabilities & equity?

Regenxbio (RGNX) reported total liabilities & equity of $341.89M in Q1 2026.

How has Regenxbio's total liabilities & equity changed year-over-year?

Regenxbio's total liabilities & equity decreased by 30.4% year-over-year, from $490.93M to $341.89M.

What is the long-term trend for Regenxbio's total liabilities & equity?

Over 5 years (2020 to 2025), Regenxbio's total liabilities & equity has grown at a -8.5% compound annual growth rate (CAGR), from $708.16M to $453.03M.

What does total liabilities & equity mean?

Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Regenxbio RGNX Total Liabilities & Equity

Total Liabilities & Equity at other companies

Regeneron PharmaceuticalsREGN

$40.87B+8.9%

Sarepta Therapeutics, Inc.SRPT

$3.18B-8.3%

BiogenBIIB

$29.48B+5.2%

BioMarin PharmaceuticalsBMRN

$8.59B+20.2%

EyePoint, Inc. EYPT

$288.22M-20.5%

Ultragenyx PharmaceuticalRARE

$1.3B-1.2%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's total liabilities & equity?: Regenxbio (RGNX) reported total liabilities & equity of $341.89M in Q1 2026.
How has Regenxbio's total liabilities & equity changed year-over-year?: Regenxbio's total liabilities & equity decreased by 30.4% year-over-year, from $490.93M to $341.89M.
What is the long-term trend for Regenxbio's total liabilities & equity?: Over 5 years (2020 to 2025), Regenxbio's total liabilities & equity has grown at a -8.5% compound annual growth rate (CAGR), from $708.16M to $453.03M.
What does total liabilities & equity mean?: Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.